Video

Dr Steven R. Feldman on Managing Psoriasis in Patients With Metabolic Syndrome

Steven R. Feldman, MD, PhD, professor of dermatology, Wake Forest School of Medicine, discusses the challenges clinicians face when managing psoriasis in patients who also have metabolic syndrome.

Steven R. Feldman, MD, PhD, professor of dermatology, Wake Forest School of Medicine, discusses the challenges clinicians face when managing psoriasis in patients who also have metabolic syndrome.

Transcript

What are some of the challenges clinicians face when managing psoriasis in patients who also have metabolic syndrome?

Psoriasis is challenging whether you have metabolic syndrome or not. There’s the challenge of making the right diagnosis. That’s not hard; we recognize psoriasis when we see it. Prescribing the right therapy can be difficult. There are so many variations of psoriasis, so many different treatments available—creams, ultraviolet light treatments, a variety of oral and injectable medicines. We have to choose from among those.

When you have a patient who has metabolic syndrome, it complicates the decisions, perhaps, a little bit, or if not complicate it, at least leads you in certain pathways as to what to use. For example, metabolic syndrome may be associated with central obesity. Those patients may have a fatty liver, and therefore, you may want to steer away from a drug like methotrexate and move towards an injectable medicine.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Mansi Shah, MD
Dr John Mascarenhas
CK Wang, MD, COTA
Dr Pankit Vachhani
Screenshot of Ivo Abraham, PhD, RN, during a video interview
Merrill H. Stewart, MD
Dr John Mascarenhas
Carla Nester, MD, MSA, FASN, Stead Family Children's Hospital
Dr John Mascarenhas
Dr Xavier Leleu
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo